Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MBA-P01 for efficacy and safety in treating glabellar lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• MBA-P01

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Frown Lines | Phase 2 | Status: COMPLETED